DSIP (Delta Sleep-Inducing Peptide)

DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide first isolated from rabbit brain tissue in 1977. It is involved in the regulation of sleep architecture, particularly the promotion of slow-wave (delta) sleep - the deepest, most restorative phase of sleep.

Delta sleep is when the body performs its most critical repair functions: growth hormone release peaks, immune function is optimized, memories are consolidated, and cellular waste products are cleared via the glymphatic system. Many people, especially those over 40, experience a progressive loss of delta sleep that contributes to accelerated aging and cognitive decline.

DSIP works differently from conventional sleep aids. Rather than inducing sedation (like benzodiazepines or Z-drugs), it normalizes the hypothalamic sleep-wake regulation system. This means it promotes natural sleep architecture without causing next-day grogginess, dependence, or rebound insomnia.

Studies have also shown DSIP's ability to normalize cortisol patterns, reduce stress-related sleep disruption, and improve sleep onset latency in insomnia patients.